Literature DB >> 16860186

Impact of comorbidities on mortality in managed care patients with CKD.

Christina M Gullion1, Douglas S Keith, Gregory A Nichols, David H Smith.   

Abstract

BACKGROUND: Our previous work showed that patients with chronic kidney disease (CKD) were 10 times more likely to die than progress to end-stage renal disease. This study examines the impact of comorbidities on mortality risk in a cohort with CKD at 3 levels of progression and a sex- and age-matched comparison group.
METHODS: In a historical, prospective, cohort study, we selected electronic medical record data for health maintenance organization (HMO) members with an index and repeated glomerular filtration rate (GFR) in the range of 15 to 90 mL/min/1.73 m(2) (0.25 to 1.50 mL/s/1.73 m(2)) in 1996 who were followed up for at least 54 months or died during this period. These were matched for birth year and sex with HMO members not meeting GFR criteria, but with the same follow-up criteria. Major comorbid chronic conditions also were identified based on International Classification of Diseases, Ninth Revision, diagnostic codes in the electronic medical record. Conditional logistic regression was used to estimate the relative risk for mortality versus comparison subjects as a function of GFR, age, and other chronic conditions.
RESULTS: In the final sample of 19,945 pairs, we found that risk for mortality increases as GFR decreases, but also that both age and other chronic conditions are significant risk factors for mortality.
CONCLUSION: Baseline levels of estimated GFR and other major chronic disorders all contributed negatively to survival. The relative impact of these comorbidities was greatest among younger (<60 years) patients with CKD, and their relative effect diminished with age.

Entities:  

Mesh:

Year:  2006        PMID: 16860186     DOI: 10.1053/j.ajkd.2006.04.083

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  18 in total

1.  Multidisciplinary team care may slow the rate of decline in renal function.

Authors:  Elizabeth A Bayliss; Bharati Bhardwaja; Colleen Ross; Arne Beck; Diane M Lanese
Journal:  Clin J Am Soc Nephrol       Date:  2011-01-27       Impact factor: 8.237

2.  Excess mortality attributable to chronic kidney disease. Results from the PIRP project.

Authors:  Dino Gibertoni; Marcora Mandreoli; Paola Rucci; Maria Pia Fantini; Angelo Rigotti; Roberto Scarpioni; Antonio Santoro
Journal:  J Nephrol       Date:  2015-10-26       Impact factor: 3.902

Review 3.  Time to re-evaluate effects of renin-angiotensin system inhibitors on renal and cardiovascular outcomes in diabetic nephropathy.

Authors:  Hiromichi Suzuki; Tomohiro Kikuta; Tsutomu Inoue; Ukihiro Hamada
Journal:  World J Nephrol       Date:  2015-02-06

4.  Reduced Cardiovascular Mortality Associated with Early Vascular Access Placement in Elderly Patients with Chronic Kidney Disease.

Authors:  Timmy Lee; Mae Thamer; Qian Zhang; Yi Zhang; Michael Allon
Journal:  Am J Nephrol       Date:  2016-05-11       Impact factor: 3.754

5.  Prognostic value of estimated glomerular filtration rate in hospitalized elderly patients.

Authors:  Laura De La Higuera; Emma Riva; Codjo Djignefa Djade; Sara Mandelli; Carlotta Franchi; Alessandra Marengoni; Francesco Salerno; Salvatore Corrao; Luca Pasina; Mauro Tettamanti; Maura Marcucci; Pier Mannuccio Mannucci; Alessandro Nobili
Journal:  Intern Emerg Med       Date:  2013-12-14       Impact factor: 3.397

6.  Outcomes of Elderly Patients after Predialysis Vascular Access Creation.

Authors:  Timmy Lee; Mae Thamer; Yi Zhang; Qian Zhang; Michael Allon
Journal:  J Am Soc Nephrol       Date:  2015-04-08       Impact factor: 10.121

7.  Chronic conditions and mortality among the oldest old.

Authors:  Sei J Lee; Alan S Go; Karla Lindquist; Daniel Bertenthal; Kenneth E Covinsky
Journal:  Am J Public Health       Date:  2008-05-29       Impact factor: 9.308

8.  A Manganese Alternative to Gadolinium for MRI Contrast.

Authors:  Eric M Gale; Iliyana P Atanasova; Francesco Blasi; Ilknur Ay; Peter Caravan
Journal:  J Am Chem Soc       Date:  2015-12-04       Impact factor: 15.419

9.  Physical and psychological burden of chronic kidney disease among older adults.

Authors:  William M McClellan; Jerome Abramson; Britt Newsome; Ella Temple; Virginia G Wadley; Paul Audhya; Leslie A McClure; Virginia J Howard; David G Warnock; Paul Kimmel
Journal:  Am J Nephrol       Date:  2010-02-13       Impact factor: 3.754

10.  Vascular disease, ESRD, and death: interpreting competing risk analyses.

Authors:  Morgan E Grams; Josef Coresh; Dorry L Segev; Lauren M Kucirka; Hocine Tighiouart; Mark J Sarnak
Journal:  Clin J Am Soc Nephrol       Date:  2012-08-02       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.